NDC 57894-071

Simponi

Golimumab

Simponi is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Janssen Biotech, Inc.. The primary component is Golimumab.

Product ID57894-071_19ce6e44-67ea-11e9-a359-5dd70099106d
NDC57894-071
Product TypeHuman Prescription Drug
Proprietary NameSimponi
Generic NameGolimumab
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2013-05-15
Marketing CategoryBLA / BLA
Application NumberBLA125289
Labeler NameJanssen Biotech, Inc.
Substance NameGOLIMUMAB
Active Ingredient Strength100 mg/mL
Pharm ClassesTumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 57894-071-01

1 SYRINGE, GLASS in 1 CARTON (57894-071-01) > 1 mL in 1 SYRINGE, GLASS
Marketing Start Date2013-05-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 57894-071-01 [57894007101]

Simponi INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125289
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-05-15

NDC 57894-071-02 [57894007102]

Simponi INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125289
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-05-15

NDC 57894-071-90 [57894007190]

Simponi INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125289
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-05-15

NDC 57894-071-89 [57894007189]

Simponi INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125289
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-05-15

Drug Details

Active Ingredients

IngredientStrength
GOLIMUMAB100 mg/mL

OpenFDA Data

SPL SET ID:f86cb4a7-c358-4136-ae57-b32bda9bba00
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1653144
  • 1653142
  • 848164
  • 848160
  • 1482813
  • 1653166
  • 1653165
  • 1482814
  • Pharmacological Class

    • Tumor Necrosis Factor Blocker [EPC]
    • Tumor Necrosis Factor Receptor Blocking Activity [MoA]

    NDC Crossover Matching brand name "Simponi" or generic name "Golimumab"

    NDCBrand NameGeneric Name
    57894-070Simponigolimumab
    57894-071Simponigolimumab
    57894-350SIMPONI ARIAgolimumab

    Trademark Results [Simponi]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SIMPONI
    SIMPONI
    77853441 3802766 Live/Registered
    JOHNSON & JOHNSON
    2009-10-21
    SIMPONI
    SIMPONI
    77510847 3772518 Live/Registered
    Johnson & Johnson
    2008-06-30
    SIMPONI
    SIMPONI
    76647994 not registered Dead/Abandoned
    JOHNSON & JOHNSON
    2005-10-05

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.